The treatment program is the largest of its kind in New Jersey, spanning RWJBarnabas Health’s 11 hospitals, and has a 95 percent success rate.
“Everything we’ve done over the last 10 months has been driven by two priorities,” Christopher Freer, DO, the system’s senior vice president for emergency and hospitalist medicine, said in a news release. “One, improve outcomes for the patients already in our care and two, preserve resources as much as possible for the next person coming through our doors. This treatment accomplishes both.”
Patients who test positive for COVID-19 and are at high risk of developing a severe infection are eligible to receive the treatment via IV at one of RWJBarnabas’ emergency rooms. After the one-hour treatment and a one-hour observation period, patients are sent home and monitored via virtual check-ins.
More articles on public health:
3 COVID-19 variants: Where they are in the US
COVID-19 precautions + the Super Bowl: 7 things to know
25% of Americans say they will attend Super Bowl parties despite health risk
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.